Coagulation reagents, consumables, maintenance, and the lease of equipment STA compact MAX3 2 units for naval hospital guam.
Ended Purchase Order Awarded Last action
- Contract number
- HT941025P0022
- Awardee
-
Medpharm Inc. UEI DLM6VHZ3VUN3
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $517,465
Award facts
- Opportunity
-
- Coagulation reagents, consumables, maintenance, and the lease of Stago Analyzers Solicitation · HT941025Q2004 · Posted Oct 30, 2024
- Contract value 36% obligated
-
- $535,871.39 Current, with exercised options
- $1,455,315.95 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Yigo, 96929, Guam
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$5,235 | |
| Funding Only Action | $284,790 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $237,910 |
About this award
The Defense Health Agency awarded a purchase order to Medpharm Inc. (doing business as Procara), a minority-owned small disadvantaged business and Asian-Pacific American-owned enterprise, for $1,455,315.95 on December 13, 2024. The order carries a total small business set-aside designation. Work is performed in Yigo, Guam, and covers coagulation reagents, consumables, maintenance, and lease of two Stago Compact MAX3 coagulation analyzer units for Naval Hospital Guam's laboratory operations. The firm fixed price order extends through September 30, 2029 and originated from a Defense Health Agency solicitation (posted October 30, 2024; due November 12, 2024) that emphasized delivery schedule over price in the evaluation.
Quick answers
Who was awarded contract HT941025P0022?
HT941025P0022 was awarded to Medpharm Inc. by Defense Health Agency (Department of Defense) on December 13, 2024.
How much is contract HT941025P0022 worth?
The government has obligated $517,465 on HT941025P0022. Its current value, with exercised options, is $535,871. Its potential value, with all options, is $1,455,316.
Was contract HT941025P0022 competed?
The extent of competition for HT941025P0022 was competed under sap. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award